We appreciate your interest in partnering with BARDA.
The latest BARDA Broad Agency Announcement (BAA) is amendment 37 posted on Jan 13, 2023.
Note: addition of new Area of Interest: 9.7 Implementation of phase 2 clinical trial to investigate novel host-directed therapeutics candidates to treat acute respiratory distress syndrome (ARDS).
All contracting related inquiries should be sent to [email protected]. BARDA will continuously review and expedite COVID-19 response related white papers and full proposals. Offerors should also complete the Submission Data Integration Table.
The final white paper submission deadline is Mar 17, 2023. The final full proposal submission deadline is Mar 17, 2023 for all AOIs except #9.7 or as specified in the invitation letter. The deadline for AOI #9.7 is March 14, 2023.